{{Rsnum
|rsid=2252281
|Gene=SLC47A1
|Chromosome=17
|position=19533874
|Orientation=plus
|GMAF=0.3255
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC47A1
}}{{PharmGKB
|RSID=rs2252281
|Name_s=SLC47A1: ?66T>C
|Gene_s=SLC47A1
|Feature=5' UTR
|Evidence=PubMed ID:19940846
|Annotation=Haplotypes containing the variant showed decreased luciferase activity in reporter assays in cells and in vivo assay.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111592
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2252281
|overall_frequency_n=9
|overall_frequency_d=42
|overall_frequency=0.214286
|n_genomes=5
|n_genomes_annotated=0
|n_haplomes=6
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23267855
|Title=The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}